With the Ebola virus becoming a major global healthcare crisis, Quorum Review IRB recognizes the imperative nature for developing new vaccines and treatments quickly. To assist investigators, medical institutions, as well as pharmaceutical sponsors and CROs, we are offering initial board review for Phase I Ebola studies at NO CHARGE.
http://us1.campaign-archive1.com/?u=75cdd3197c4f2f278789c2b54&id=fe3bcb24d8&e=728640ad3b
